Polydex Pharmaceuticals
(OTC) POLXF
This security has been delisted. This page is retained for historical reference.
POLXF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowPOLXF Financials
Key Financial Metrics (TTM)
Gross Margin
-2%
Operating Margin
-26%
Net Income Margin
-49%
Return on Equity
-53%
Return on Capital
-29%
Return on Assets
-38%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
-1.45%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$91.72K
Operating Income
$1.18M
EBITDA
$745.93K
Operating Cash Flow
$589.72K
Capital Expenditure
$68.33K
Free Cash Flow
$658.05K
Cash & ST Invst.
$375.00K
Total Debt
$1.14M
Polydex Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$1.06M
+13.9%
Gross Profit
$177.37K
+20.6%
Gross Margin
-16.66%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
20
N/A
Net Income
$1.38M
-33.8%
EBITDA
$1.25M
-2.9%
Quarterly Fundamentals
Net Cash
$765.09K
-230.0%
Accounts Receivable
$535.90K
+231.1%
Inventory
$1.18M
+18.0%
Long Term Debt
$566.95K
-36.3%
Short Term Debt
$573.14K
+1031.9%
Return on Assets
-38.27%
N/A
Return on Invested Capital
-29.12%
N/A
Free Cash Flow
$156.85K
-127.3%
Operating Cash Flow
$140.63K
-125.5%